Aclarion, Inc. financial data

Symbol
ACON, ACONW on Nasdaq
Industry
Services-Medical Laboratories
Location
8181 Arista Place, Ste 100, Broomfield, CO
State of incorporation
DE
Fiscal year end
December 31
Former names
Nocimed, Inc. (to 10/26/2021)
Latest financial report
10-K - Q4 2024 - Apr 9, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 158 % +319%
Debt-to-equity 110 %
Return On Equity -367 % -108%
Return On Assets -231 % +7.62%
Operating Margin -12.1K % -86.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 582K shares -91.9%
Common Stock, Shares, Outstanding 10M shares +22%
Entity Public Float 2.33M USD -50.1%
Common Stock, Value, Issued 0 USD -100%
Weighted Average Number of Shares Outstanding, Basic 943K shares
Weighted Average Number of Shares Outstanding, Diluted 943K shares

Income Statement

Label TTM Value / Value Unit Change %
Revenues 45.7K USD -39.4%
Cost of Revenue 84.7K USD +11.8%
Research and Development Expense 889K USD +1.77%
Selling and Marketing Expense 977K USD +29%
General and Administrative Expense 3.61M USD +11.2%
Operating Income (Loss) -5.51M USD -13.1%
Nonoperating Income (Expense) -1.48M USD -4081%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -6.99M USD -42.4%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -6.99M USD -42.4%
Earnings Per Share, Basic -0.15 USD/shares +92%
Earnings Per Share, Diluted -0.15 USD/shares +92%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 454K USD -55.6%
Accounts Receivable, after Allowance for Credit Loss, Current 18.3K USD +38.1%
Assets, Current 824K USD -36.1%
Property, Plant and Equipment, Net 5.5K USD +209%
Intangible Assets, Net (Excluding Goodwill) 1.29M USD +10.7%
Assets 2.12M USD -13.7%
Accounts Payable, Current 532K USD -30.1%
Accrued Liabilities, Current 12.1K USD
Liabilities, Current 1.15M USD -63.8%
Liabilities 678K USD
Retained Earnings (Accumulated Deficit) -51.3M USD -15.8%
Stockholders' Equity Attributable to Parent 970K USD
Liabilities and Equity 2.12M USD -13.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.24M USD -121%
Net Cash Provided by (Used in) Financing Activities 3.41M USD
Net Cash Provided by (Used in) Investing Activities -63.7K USD -443%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 10M shares +22%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 464K USD -55%
Deferred Tax Assets, Valuation Allowance 11M USD +12.9%
Deferred Tax Assets, Gross 11M USD +12.9%
Property, Plant and Equipment, Gross 60.3K USD +9.27%
Deferred Tax Assets, Operating Loss Carryforwards 10.4M USD +13%
Preferred Stock, Shares Authorized 20M shares 0%
Additional Paid in Capital 52.2M USD +19.9%
Amortization of Intangible Assets 192K USD +19%
Depreciation, Depletion and Amortization 45.1K USD +14.6%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 445K USD -66.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%